BioPharmGuy logo
Glen Research

AmbAgon Therapeutics

Founded 2020; Website

Categories (key): SM


HQ: San Francisco, CA - Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins

Eindhoven, Netherlands

If you believe any of this information is incorrect, please let us know.